News | January 22, 2021
Syngene Q3 revenue up 13% to Rs. 585 Cr
EBITDA and PAT for the quarter were both up 11% to Rs. 193 crores and Rs. 102 crores respectively.
EBITDA and PAT for the quarter were both up 11% to Rs. 193 crores and Rs. 102 crores respectively.
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
Health ministry notifies amendments to the Drugs Rules, 1945 to expand the ambit of Schedule H2 and bring additional categories of drugs under the QR Code-based track and trace framework
Objective Structured Clinical Examination (OSCE) are widely used to evaluate medical students' practical competencies, communication, professionalism, and clinical decision-making
The Trivitron Healthcare CMD and FICCI Tamil Nadu Chairman was honoured for advancing indigenous innovation and strengthening India's healthcare ecosystem
In his new role, he will lead the company's growth strategy across Africa, strengthen healthcare partnerships, and expand access to innovative diagnostic solutions
The offer is being made through Harmony Row Acquisition Co., a wholly owned GSK subsidiary, and targets all outstanding Class A and Class B shares of Nuvalent
The company emphasized that its mRNA system is built on three pillars—mRNA science, delivery science, and manufacturing processes
Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience
Experts announce upcoming Amyotrophic lateral sclerosis (ALS) studies, advocate early diagnosis, comprehensive care, and stronger support systems for patients and caregivers
Subscribe To Our Newsletter & Stay Updated
